Publicacións en colaboración con investigadores/as de Universidade da Coruña (6)

2020

  1. Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram

    Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 351-359

  2. First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial

    Clinical and Translational Oncology, Vol. 22, Núm. 4, pp. 495-502

  3. Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR?

    International Journal of Colorectal Disease, Vol. 35, Núm. 4, pp. 739-746

2017

  1. Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

    European Journal of Cancer, Vol. 82, pp. 16-24

2010

  1. A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer

    British Journal of Cancer, Vol. 103, Núm. 10, pp. 1536-1541

  2. Efficacy of epoetin-beta 30,000 IU/week in correcting anaemia in patients with gastrointestinal tumours subjected to concomitant chemoradiotherapy

    Clinical and Translational Oncology, Vol. 12, Núm. 12, pp. 843-848